Add Formweb to your mobile device
Search results for:
elranatamab
elranatamab
Brand names: Elrexfio
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SOLUTION, SUBCUTANEOUS | bcmm 40 mg/mL |
Last updated: Dec. 9, 2024
elranatamab
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SOLUTION, SUBCUTANEOUS | bcmm 40 mg/mL |
Due to risk of CRS, patients should be hospitalized for 48 hours after step-up dose 1, and 24 hours after step-up dose 2.